The Medical Device Business Journal — Medical Device News & Articles | MassDevice
SpinalMotion said it’s raised another $10.5 million, taking the total raised in the funding round to $25.5 million, according to a regulatory filing.
The Mountain View, Calif.-based medical device company raised the cash in an offering of equity, debt, options and warrants to 15 unnamed investors, according to the filing.
Mountain View, Calif.-based medical device maker SpinalMotion will get its date with the FDA this summer, when a panel of experts will consider and make recommendations on the company’s Kineflex/C artificial disc.
On July 24, 2013, the FDA’s orthopedic & rehabilitation devices panel will review information on the Kineflex/C and made a recommendation on whether the federal watchdog agency should approve the device for the U.S. market.
SpinalMotion closed the final tranche of a $15 million funding round that began in June 2011, according to a regulatory filing.
The Mountain View, Calif.-based medical device company raised a total of $15.1 million in the offering of debt, options and warrants from 15 unnamed investors, according to the filing.
Misonix (NSDQ:MSON) shares are up 19% today after the medical device company swung to black ink for its fiscal 4th quarter and full year.
Farmingdale, N.Y.-based Misonix posted profits of $366,000, or 5¢ per share, on sales of $1.7 million for the 12 months ended June 30 – for a 26.7% top-line gain that helped Misonix swing from a $3.5 million loss during its last fiscal year.
Urologix Inc. (NSDQ:ULGX) is heralding the results of a long-term study on its enlarged prostate treatment device.
Data from a study published in The Journal of Urology show that the Minneapolis-based medical device manufacturer’s Cooled ThermoTherapy (CTT) is safe and effective at treating both symptoms and obstruction associated with benign prostatic hyperplasia (BPH), the company reported.
